Medtech expert Smith+Nephew has announced a new partnership with Standard Health to support the development of the UK’s first-ever Orthopaedic Ambulatory Surgery Centre.
The new centre is to be based in Poole, Dorset.
The Orthopaedic Ambulatory Surgery Centre is planned to offer NHS and private patients access to leading joint repair and replacement technology.
These technologies can address conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wrist procedures.
Standard Health is a clinical healthcare provider, responsible for site development and operation of the facility, with Smith+Nephew supplying its portfolio of medical technologies.
Standard Health expects to open a further 10 additional UK sites in the following three years and 20 in total by 2030.
The new centre in Poole will cover day and overnight-stay cases, which make up the vast majority of orthopaedic procedures.
Standard Health expects to open a further 10 additional UK sites in the following three years and 20 in total by 2030
The design will mirror the Ambulatory Surgery Centre (ASC) model in the US, where Smith+Nephew is a major partner to many sports medicine and orthopaedic facilities. Benefits derived from US-based ASC settings for both HCPs and their patients are well documented, and may include:
- Greater procedural efficiency due to streamlined workflows
- A 92% patient satisfaction rate for both care and service received from ASCs
- Decreased costs to the health system. In the US, outpatient joint replacements at ASCs reduce the costs of joint replacements by 40% compared to hospital-based surgery
There are currently more than 6,000 ASCs in the US that account for greater than 50% of all outpatient surgical procedures.
There are currently more than 850,000 people waiting for orthopaedic surgery in the UK
The Orthopaedic Ambulatory Surgery Centre in Poole is expected to open in 2025 and serve thousands of patients per calendar year, with the majority being NHS referrals.
There are currently more than 850,000 people waiting for orthopaedic surgery in the UK. As a result, the NHS commissioning landscape is reliant on independent providers to address this demand.
“The Standard Health Orthopaedic Ambulatory Surgical Centre model will bring the benefits long enjoyed by US patients to those on waiting lists in the UK,” said Craig Gaffin, President of Global Orthopaedics at Smith+Nephew.
Gaffin also emphasised the company’s expertise in orthopaedic, sports medicine and wound management medical technology as a benefit.
“Our goal is to help shape and redefine the UK independent care provider model for orthopaedics based on existing successful models and technologies globally, including empowering surgeons as stakeholders. This will provide a standard quality of care for patients as well as value for NHS commissioners which is sustainable long-term,” said Matt Byrne, Chief Operating Officer for Standard Health.
“The amount of time patients must wait for a procedure in the UK needs to improve. We chose to partner with Smith+Nephew to accelerate the implementation and ultimately help deliver the success of these surgical centres.”